Skin Permeation Profile of Clindamycin in Foam and Gel Formulations

H Tanojo,J Lenn,X Huang

DOI: https://doi.org/10.1016/j.jaad.2003.11.011

IF: 15.487

2004-01-01

Journal of the American Academy of Dermatology

Abstract:Previous reports and publications showed that the foam vehicle delivers the active drug via a vehicle-skin non-interactive pathway compared to other traditional vehicles. This novel vehicle has been successfully used in clinical trials to deliver topical corticosteroids and ant fungal drugs. Recently, the foam formulation of clindamycin phosphate has been used in clinical studies for the treatment of acne. Objectives: To compare the skin permeation and distribution profile of clindamycin in foam vehicle with a clindamycin gel formulation. Methods: In vitro permeation through split-thickness human skin (∼0.25 mm) was measured using flow-through diffusion cells. Clindamycin foam and gel were applied on three or four replicate sections from each of three human donors. Receptor fluid was collected at 4-hour intervals. At 24 hours after application, the skin was washed and split into epidermis and dermis to measure drug content within these layers. The drug content in samples was measured by HPLC-MS. Results and Conclusions: The foam and gel each reached the maximum rate of delivery soon after application, although the foam had a higher rate than the gel. Subsequently, the permeation rate for both vehicles decreased, however the foam continued to deliver at a higher rate. The amount of clindamycin passing through the skin into the receptor fluid from the foam formulation was more than that of the gel at all time points. The results suggest that foam is a more effective vehicle to deliver clindamycin into the skin than gel.